This comes during a time when when Eli Lilly and Novo Nordisk have been garnering momentum—last week, the FDA added ...
WeightWatchers' CEO said on Wednesday it planned to offer Novo Nordisk's much-anticipated Wegovy in pill form if it is ...
End of Period Subscribers of 3.0 million, including Clinical Subscribers of 124 thousand Total Revenues of $172 million; Clinical Subscription Revenues of $26 million, up 35% year-over-year Net Loss ...
Anviksha Patel is a London-based reporter for MarketWatch, where she covers hedge funds and short sellers. She can be found on Twitter @annieiseating. Back To Top ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback